Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study

• Yuan Yang,
• Zengwei Tang,
• Yuzhou Huang,
• Qinglin Hu,
• Shuqing Wang,
• Jiang Ji,
• Yali Du,
• Chen Yang,
• Miao Chen,
• Shimin Hu,
• Bing Han

Affiliations

Yuan Yang

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Zengwei Tang

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University

Yuzhou Huang

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Qinglin Hu

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Shuqing Wang

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Jiang Ji

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Yali Du

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Chen Yang

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Miao Chen

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Shimin Hu

Department of Hematopathology, The University of Texas MD Anderson Cancer Center

Bing Han

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College